Radiation doses received during a criticality accident will be from a combination of fission spectrum neutrons and gamma rays. It is desirable to estimate the total dose, as well as the neutron and gamma doses. Present methods for dose estimation with chromosome aberrations after a criticality accident use point estimates of the neutron to gamma dose ratio obtained from personnel dosemeters and/or accident reconstruction calculations. In this paper a Bayesian approach to dose estimation with chromosome aberrations is developed which allows the uncertainty of the dose ratio to be considered. Posterior probability densities for the total and the neutron and gamma doses were derived.
The mortality pattern of women who began employment as luminizers in the radium dial industry before 1930 was followed through 1990. Hazard models with time-dependent covariates were used on mortality data either organized by individual death times or grouped into cross-classified person-year tables. These models were used to quantify trends in mortality associated with either death from or diagnosis of bone sarcoma or head carcinoma. The accumulation of skeletal doses from 226Ra and 225Ra was an important predictor of the risk of death from bone sarcoma. Women exposed to 226Ra at ages associated with active bone growth were at greater risk of bone sarcoma than women receiving even larger exposures at an age when their skeletons would have been fully developed. Exposure to only 226Ra was found to be an important predictor of risk for carcinoma of the mastoid air cells and paranasal sinuses. For the cranial sites, where adult dimensions are attained early in life, an effect of age at exposure could not be detected.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.